Np mrd loader

Record Information
Version1.0
Created at2021-01-06 06:37:45 UTC
Updated at2021-07-15 17:36:10 UTC
NP-MRD IDNP0021371
Secondary Accession NumbersNone
Natural Product Identification
Common NameMoenomycin H
Provided ByNPAtlasNPAtlas Logo
DescriptionMoenomycin H belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. Moenomycin H is found in Streptomyces. It was first documented in 1969 (PMID: 4312665). Based on a literature review a significant number of articles have been published on Moenomycin H (PMID: 26389402) (PMID: 34428003) (PMID: 26389465) (PMID: 26389390) (PMID: 26389303) (PMID: 26389290).
Structure
Thumb
Synonyms
ValueSource
(2R)-2-Hydroxy-3-{[hydroxy({[(4S)-5-hydroxy-3-{[(4R)-4-hydroxy-5-{[(4R)-4-hydroxy-3-[(1-hydroxyethylidene)amino]-6-methyl-5-{[(2R,5R)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-C-hydroxycarbonimidoyl]oxan-2-yl]oxy}oxan-2-yl]oxy}-3-[(1-hydroxyethylidene)amino]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-6-(C-hydroxycarbonimidoyl)-4-(C-hydroxycarbonimidoyloxy)oxan-2-yl]oxy})phosphoryl]oxy}propanoateGenerator
Chemical FormulaC43H66N5O34P
Average Mass1227.9760 Da
Monoisotopic Mass1227.33268 Da
IUPAC Name(2R)-3-[({[(2S,3R,4S,5S,6S)-6-carbamoyl-4-(carbamoyloxy)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5R,6S)-3-acetamido-4-hydroxy-6-methyl-5-{[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5-hydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]-2-hydroxypropanoic acid
Traditional Name(2R)-3-({[(2S,3R,4S,5S,6S)-6-carbamoyl-4-(carbamoyloxy)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5R,6S)-3-acetamido-4-hydroxy-6-methyl-5-{[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-5-hydroxyoxan-2-yl]oxy(hydroxy)phosphoryl}oxy)-2-hydroxypropanoic acid
CAS Registry NumberNot Available
SMILES
CC1OC(OC2[C@H](O)C(NC(C)=O)C(OC3C(OP(O)(=O)OC[C@@H](O)C(O)=O)OC(C(O)[C@@H]3OC(N)=O)C(N)=O)OC2COC2OC(CO)C(O)C(O)C2O)C(NC(C)=O)[C@@H](O)C1O[C@@H]1OC([C@H](O)C(O)C1O)C(=O)NC1=C(O)CCC1=O
InChI Identifier
InChI=1S/C43H66N5O34P/c1-9-29(76-41-27(62)24(59)25(60)33(79-41)36(65)48-17-12(52)4-5-13(17)53)21(56)18(46-10(2)50)38(73-9)77-30-16(8-71-40-26(61)23(58)20(55)15(6-49)74-40)75-39(19(22(30)57)47-11(3)51)80-34-31(81-43(45)68)28(63)32(35(44)64)78-42(34)82-83(69,70)72-7-14(54)37(66)67/h9,14-16,18-34,38-42,49,52,54-63H,4-8H2,1-3H3,(H2,44,64)(H2,45,68)(H,46,50)(H,47,51)(H,48,65)(H,66,67)(H,69,70)/t9?,14-,15?,16?,18?,19?,20?,21-,22-,23?,24?,25-,26?,27?,28?,29?,30?,31+,32?,33?,34?,38?,39?,40?,41-,42?/m1/s1
InChI KeyAYPBINFDHGMDSL-JHNAURKQSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
StreptomycesNPAtlas
Chemical Taxonomy
Description Belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct ParentOligosaccharides
Alternative Parents
Substituents
  • Oligosaccharide
  • N-acyl-alpha-hexosamine
  • Glycosyl compound
  • O-glycosyl compound
  • Glyceric_acid
  • Dialkyl phosphate
  • Alpha-hydroxy acid
  • Hydroxy acid
  • Organic phosphoric acid derivative
  • Oxane
  • Phosphoric acid ester
  • Pyran
  • Alkyl phosphate
  • Carbamic acid ester
  • Acetamide
  • Vinylogous acid
  • Ketone
  • Secondary carboxylic acid amide
  • Carbonic acid derivative
  • Secondary alcohol
  • Cyclic ketone
  • Carboxamide group
  • Primary carboxylic acid amide
  • Oxacycle
  • Carboxylic acid
  • Acetal
  • Carboxylic acid derivative
  • Polyol
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Primary alcohol
  • Organic nitrogen compound
  • Alcohol
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Carbonyl group
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-1.3ALOGPS
logP-11ChemAxon
logS-2.1ALOGPS
pKa (Strongest Acidic)1.57ChemAxon
pKa (Strongest Basic)-3.9ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count31ChemAxon
Hydrogen Donor Count19ChemAxon
Polar Surface Area618.67 ŲChemAxon
Rotatable Bond Count23ChemAxon
Refractivity250.31 m³·mol⁻¹ChemAxon
Polarizability110.94 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA005192
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID78445769
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound139584542
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Schacht U, Huber G: Moenomycin. VII. Isolation and properties of further components of the antibiotic moenomycin. J Antibiot (Tokyo). 1969 Dec;22(12):597-602. [PubMed:4312665 ]
  2. Authors unspecified: Rectal Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389402 ]
  3. McDermott KW, Roemer M: Most Frequent Principal Diagnoses for Inpatient Stays in U.S. Hospitals, 2018: Statistical Brief #277. 2006 Feb. [PubMed:34428003 ]
  4. Authors unspecified: Adult Primary Liver Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389465 ]
  5. Authors unspecified: Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ(R)): Patient Version. 2002. [PubMed:26389390 ]
  6. Authors unspecified: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ(R)): Patient Version. 2002. [PubMed:26389303 ]
  7. Authors unspecified: Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ(R)): Patient Version. 2002. [PubMed:26389290 ]
  8. Zheng L, Tian J, Liu D, Zhao Y, Fang X, Zhang Y, Liu Y: Efficacy and safety of roxadustat for anaemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Aug 24. doi: 10.1111/bcp.15055. [PubMed:34428860 ]
  9. Ueda M, Sato Y, Iwami S, Dodo T, Shirase T, Fujita K: Temporal changes in magnetic resonance imaging appearance of adult granulosa cell tumor. J Obstet Gynaecol Res. 2021 Aug 24. doi: 10.1111/jog.14995. [PubMed:34428859 ]